ELUCIREM and VUEWAY Guerbet Australia Pty Ltd
Product name
ELUCIREM and VUEWAY
Sponsor
Accepted date
Apr-2024
Active ingredients
gadopiclenol
Proposed indication
Indicated for contrast-enhanced magnetic resonance imaging (MRI) to detect and visualise lesions with abnormal blood brain barrier or abnormal vascularity.
Application type
A (new medicine)
Publication date
Apr-2024